| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |